BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abarca K, Ibánez I, Perret C, Vial P, Zinsou JA. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children. Int J Infect Dis. 2008;12:270-277. [PMID: 17988917 DOI: 10.1016/j.ijid.2007.08.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Sudjaritruk T, Sirisanthana T, Sirisanthana V. ANTIBODY RESPONSES TO HEPATITIS A VIRUS VACCINATION IN THAI HIV-INFECTED CHILDREN WITH IMMUNE RECOVERY AFTER ANTIRETROVIRAL THERAPY. Pediatric Infectious Disease Journal 2011;30:256-9. [DOI: 10.1097/inf.0b013e3181f812f8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
2 Gouvêa Ade F, Pinto MI, Miyamoto M, Machado DM, Pessoa SD, Carmo FB, Beltrão SC, Succi RC. [Persistence of hepatitis A virus antibodies after primary immunization and response to revaccination in children and adolescents with perinatal HIV exposure]. Rev Paul Pediatr 2015;33:142-9. [PMID: 25918013 DOI: 10.1016/j.rpped.2014.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Crisinel PA, Posfay-Barbe KM, Aebi C, Cheseaux JJ, Kahlert C, Rudin C, Nadal D, Siegrist CA; Swiss Mother and Child HIV Cohort Study of Switzerland. Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected children living in Switzerland. Clin Vaccine Immunol 2012;19:1751-7. [PMID: 22933400 DOI: 10.1128/CVI.00264-12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
4 Van Effelterre T, De Antonio-Suarez R, Cassidy A, Romano-Mazzotti L, Marano C. Model-based projections of the population-level impact of hepatitis A vaccination in Mexico. Hum Vaccin Immunother 2012;8:1099-108. [PMID: 22854667 DOI: 10.4161/hv.20549] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
5 Li RC, Li Y, Yi N, Huang L, Wan Z, Zhang Y, Rasuli A. An open, prospective, randomized study comparing the immunogenicity and safety of two inactivated hepatitis A pediatric vaccines in toddlers, children and adolescents in China. Pediatr Infect Dis J 2013;32:e77-81. [PMID: 23334341 DOI: 10.1097/INF.0b013e318271c4c3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
6 Carlos F, Gómez JA, Anaya P, Romano-Mazzotti L. Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico. Hum Vaccin Immunother 2016;12:52-63. [PMID: 26503702 DOI: 10.1080/21645515.2015.1065362] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
7 Zhang ZL, Zhu XJ, Wang X, Liang M, Sun J, Liu Y, Gao ZG, Wu JY, Dong XJ, Liu RK, Chen JT, Zhang YQ, Wang W, Zhang LP, Yin W. Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children. Vaccine 2012;30:4028-33. [PMID: 22537990 DOI: 10.1016/j.vaccine.2012.04.038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
8 Hong SS, Choi UY, Ma SH, Lee SY, Han SB, Kim KH, Kang JH, Kim JH. Comparison of the immunogenicity and safety of 3 inactivated hepatitis A vaccines in Korean children aged 12 to 18 months: An open-label, randomized, prospective, multicenter study. Medicine (Baltimore) 2019;98:e14364. [PMID: 30732169 DOI: 10.1097/MD.0000000000014364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Shouval D. Immunization against Hepatitis A. Cold Spring Harb Perspect Med 2019;9:a031682. [PMID: 29661808 DOI: 10.1101/cshperspect.a031682] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Weinberg A, Allshouse AA, Mawhinney S, Canniff J, Benning L, Wentz EL, Minkoff H, Young M, Nowicki M, Greenblatt R. Responses to hepatitis A virus vaccine in HIV-infected women: effect of hormonal contraceptives and HIV disease characteristics. J Acquir Immune Defic Syndr. 2012;60:e15-e18. [PMID: 22517417 DOI: 10.1097/qai.0b013e31824d30bd] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
11 Xu Q, Cao Q, Yang W, Liu X, Liu H, Tian X, Li J, Fang X, Jia N, Zeng G, Xu A. Interchangeability of two Enterovirus 71 inactivated vaccines in Chinese children: A phase IV, open-label, and randomized controlled trial. Vaccine 2020;38:2671-7. [PMID: 32067817 DOI: 10.1016/j.vaccine.2020.02.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Thuluva S, Matur R, Tsa K, Gv SR. A single blind randomized phase 3 study to evaluate safety and immunogenicity of inactivated hepatitis A vaccine (HAPIBEVTM) in 1-15 years-old healthy hepatitis A vaccine-naïve children. Vaccine 2021;39:7166-74. [PMID: 34763950 DOI: 10.1016/j.vaccine.2021.10.018] [Reference Citation Analysis]
13 Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol 2012; 4(3): 68-73 [PMID: 22489258 DOI: 10.4254/wjh.v4.i3.68] [Cited by in Crossref: 157] [Cited by in F6Publishing: 112] [Article Influence: 15.7] [Reference Citation Analysis]
14 Zhang L. Hepatitis A vaccination. Hum Vaccin Immunother 2020;16:1565-73. [PMID: 32649265 DOI: 10.1080/21645515.2020.1769389] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Bravo C, Mege L, Vigne C, Thollot Y. Clinical experience with the inactivated hepatitis A vaccine, Avaxim 80U Pediatric. Expert Rev Vaccines 2019;18:209-23. [PMID: 30806110 DOI: 10.1080/14760584.2019.1580578] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
16 Shi N, Rasuli A, Thollot Y. Safety of two doses of an inactivated hepatitis a vaccine given 6 months apart in healthy toddlers, children, and adolescents aged 12 months to 15 years in China: a phase IV study. Hum Vaccin Immunother 2019;15:748-54. [PMID: 30403910 DOI: 10.1080/21645515.2018.1539600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Yoon SH, Kim HW, Ahn JG, Kim IT, Kim JH, Kong KA, Kim KH. Reappraisal of the Immunogenicity and Safety of Three Hepatitis A Vaccines in Adolescents. J Korean Med Sci 2016;31:73-9. [PMID: 26770041 DOI: 10.3346/jkms.2016.31.1.73] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
18 Averhoff FM, Khudyakov Y, Nelson NP. Hepatitis A Vaccines. Plotkin's Vaccines. Elsevier; 2018. pp. 319-341.e15. [DOI: 10.1016/b978-0-323-35761-6.00024-9] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
19 Boggild AK, Castelli F, Gautret P, Torresi J, von Sonnenburg F, Barnett ED, Greenaway CA, Lim PL, Schwartz E, Wilder-Smith A, Wilson ME; GeoSentinel Surveillance Network. Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network. Vaccine 2010;28:7389-95. [PMID: 20851081 DOI: 10.1016/j.vaccine.2010.09.009] [Cited by in Crossref: 90] [Cited by in F6Publishing: 75] [Article Influence: 7.5] [Reference Citation Analysis]
20 Kwak GY, Kwon HJ, Kim JH, Kim HM, Park JS, Ma SH, Kim JG, Kang JH. The immunogenicity and safety of DTaP interchangeable immunization among Korean children. Vaccine 2012;30:4644-7. [DOI: 10.1016/j.vaccine.2012.04.094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
21 Murphy TV, Feinstone SM, Bell BP. Hepatitis A vaccines. Vaccines. Elsevier; 2013. pp. 183-204. [DOI: 10.1016/b978-1-4557-0090-5.00008-2] [Cited by in Crossref: 9] [Article Influence: 1.0] [Reference Citation Analysis]